Mubadala Ventures is the venture capital arm of Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund. It invests in advanced technology companies across the US, Europe, and the Middle East, with sector focuses including AI, healthcare, and enterprise technology.
Average disclosed round size is $323.2M (across 161 rounds with reported amounts).
Portfolio
121
Fund Size
$400M
Top Stage
Series B
Last 12 Mo
9
Team
Fabrizio Bocciardi
Senior Partner, Head of Credit
Ibrahim Ajami
Senior Partner, Head of Ventures
Maxime Franzetti
Senior Partner, Head of Solutions
Sergio Carneiro
Partner
Abdul Razzak El Jarkass
Principal, Strategic Partnerships & Acquisitions
Abdulla Al Mir
Principal
Abdalla Al Harmoodi
Senior Associate, Finance
Abdulla Lootah
Senior Associate
Abhijeet Ashtekar
Senior Associate
Abthal Monir
Associate, Business Development & Investor Relations
Omar Eraiqat
President, Chief Investment Officer, Credit and Solutions
Oscar Fahlgren
President, Chief Investment Officer, Private Equity
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Precision | Series D | $250M | Sep 2026 |
 Crusoe | Series F | $3.9B | Sep 2026 |
| OOllin | Series B | $330M | Jun 2026 |
 L-Nutra | Series D | $36.5M | Jan 2026 |
| OOdoo S.A. | Unknown | — | Jan 2026 |
 Juvena Therapeutics | Series B | $33.5M | Jan 2026 |
 Alloy Therapeutics | Series E | $40M | Jan 2026 |
 Ollin Biosciences | Series B | $330M | Jan 2026 |
| SSalma Health | Series A | $80M | Jan 2026 |
 Paradigm Health | Series B | $78M | Dec 2025 |
 Paradigm | Growth | — | Dec 2025 |
 Crusoe | Series E | $1.4B | Oct 2025 |
 Electra | Series C | $183M | Oct 2025 |
| EElectra Therapeutics | Series C | $183M | Oct 2025 |
 Tahoe Therapeutics | Series A | $30M | Aug 2025 |
| DDiot-Siaci | Unknown | — | Aug 2025 |
| DDiot-Siaci | Unknown | — | Aug 2025 |
 Anaconda | Series C | $150M | Jul 2025 |
| TTenvie | Unknown | $200M | Jan 2025 |
| Anaconda | Series C | $150M | Jan 2025 |
| CCrusoe AI | Series E | — | Jan 2025 |
| Crusoe | Series E | — | Jan 2025 |
| Crusoe | Series D | $600M | Dec 2024 |
| CCrusoe AI | Series D | $600M | Dec 2024 |
 Metsera | Series B | — | Nov 2024 |
Top Co-Investors
Last updated: 7 October 2026